Molecular biomarkers for lung adenocarcinoma von Calvayrac, Olivier, Pradines, Anne, Pons, Elvire, Mazières, Julien, Guibert, Nicolas

Volltext

Targeting the immune system to treat lung cancer: rationale and clinical experience von Guibert, Nicolas, Delaunay, Myriam, Mazières, Julien

Volltext

Detection of Tumor Recurrence via Circulating Tumor DNA Profiling in Patients with Localized Lung Cancer: Clinical Considerations and Challenges von Ulrich, Bryan, Pradines, Anne, Mazières, Julien, Guibert, Nicolas

Volltext

Druggable redox pathways against Mycobacterium abscessus in cystic fibrosis patient-derived airway organoids von Leon-Icaza, Stephen Adonai, Bagayoko, Salimata, Vergé, Romain, Iakobachvili, Nino, Ferrand, Chloé, Aydogan, Talip, Bernard, Célia, Sanchez Dafun, Angelique, Murris-Espin, Marlène, Mazières, Julien, Bordignon, Pierre Jean, Mazères, Serge, Bernes-Lasserre, Pascale, Ramé, Victoria, Lagarde, Jean-Michel, Marcoux, Julien, Bousquet, Marie-Pierre, Chalut, Christian, Guilhot, Christophe, Clevers, Hans, Peters, Peter J, Molle, Virginie, Lugo-Villarino, Geanncarlo, Cam, Kaymeuang, Berry, Laurence, Meunier, Etienne, Cougoule, Céline

Volltext

Reply to Gille and collaborators: DM and VC impairment after COVID-1 von Elise, Noel-Savina, Marion, Dupuis, Grégoire, Prévot, Julien, Mazières, Alain, Didier

Volltext

Overexpression of Claspin and Timeless protects cancer cells from replication stress in a checkpoint-independent manner von Bianco, Julien N., Bergoglio, Valérie, Lin, Yea-Lih, Pillaire, Marie-Jeanne, Schmitz, Anne-Lyne, Gilhodes, Julia, Lusque, Amelie, Mazières, Julien, Lacroix-Triki, Magali, Roumeliotis, Theodoros I., Choudhary, Jyoti, Moreaux, Jérôme, Hoffmann, Jean-Sébastien, Tourrière, Hélène, Pasero, Philippe

Volltext

Trastuzumab Deruxtecan in HER2-Mutant Non–Small-Cell Lung Cancer von Li, Bob T, Smit, Egbert F, Goto, Yasushi, Nakagawa, Kazuhiko, Udagawa, Hibiki, Mazières, Julien, Nagasaka, Misako, Bazhenova, Lyudmila, Saltos, Andreas N, Felip, Enriqueta, Pacheco, Jose M, Pérol, Maurice, Paz-Ares, Luis, Saxena, Kapil, Shiga, Ryota, Cheng, Yingkai, Acharyya, Suddhasatta, Vitazka, Patrik, Shahidi, Javad, Planchard, David, Jänne, Pasi A

Volltext

Pembrolizumab plus Chemotherapy for Squamous Non–Small-Cell Lung Cancer von Paz-Ares, Luis, Luft, Alexander, Vicente, David, Tafreshi, Ali, Gümüş, Mahmut, Mazières, Julien, Hermes, Barbara, Çay Şenler, Filiz, Csőszi, Tibor, Fülöp, Andrea, Rodríguez-Cid, Jerónimo, Wilson, Jonathan, Sugawara, Shunichi, Kato, Terufumi, Lee, Ki Hyeong, Cheng, Ying, Novello, Silvia, Halmos, Balazs, Li, Xiaodong, Lubiniecki, Gregory M, Piperdi, Bilal, Kowalski, Dariusz M

Volltext

Pembrolizumab Plus Chemotherapy in Squamous Non-Small-Cell Lung Cancer: 5-Year Update of the Phase III KEYNOTE-407 Study von Novello, Silvia, Kowalski, Dariusz M, Luft, Alexander, Gümüş, Mahmut, Vicente, David, Mazières, Julien, Rodríguez-Cid, Jeronimo, Tafreshi, Ali, Cheng, Ying, Lee, Ki Hyeong, Golf, Alexander, Sugawara, Shunichi, Robinson, Andrew G, Halmos, Balazs, Jensen, Erin, Schwarzenberger, Paul, Pietanza, M Catherine, Paz-Ares, Luis

Volltext

A Randomized, Placebo-Controlled Trial of Pembrolizumab Plus Chemotherapy in Patients With Metastatic Squamous NSCLC: Protocol-Specified Final Analysis of KEYNOTE-407 von Paz-Ares, Luis, Vicente, David, Tafreshi, Ali, Robinson, Andrew, Soto Parra, Hector, Mazières, Julien, Hermes, Barbara, Cicin, Irfan, Medgyasszay, Balazs, Rodríguez-Cid, Jerónimo, Okamoto, Isamu, Lee, SungSook, Ramlau, Rodryg, Vladimirov, Vladimir, Cheng, Ying, Deng, Xuan, Zhang, Ying, Bas, Tuba, Piperdi, Bilal, Halmos, Balazs

Volltext

Activity and safety of nivolumab, an anti-PD-1 immune checkpoint inhibitor, for patients with advanced, refractory squamous non-small-cell lung cancer (CheckMate 063): a phase 2, s... von Rizvi, Naiyer A, Dr, Mazières, Julien, Prof, Planchard, David, MD, Stinchcombe, Thomas E, MD, Dy, Grace K, MD, Antonia, Scott J, MD, Horn, Leora, MD, Lena, Hervé, MD, Minenza, Elisa, MD, Mennecier, Bertrand, MD, Otterson, Gregory A, MD, Campos, Luis T, MD, Gandara, David R, MD, Levy, Benjamin P, MD, Nair, Suresh G, MD, Zalcman, Gérard, Prof, Wolf, Jürgen, Prof, Souquet, Pierre-Jean, MD, Baldini, Editta, MD, Cappuzzo, Federico, MD, Chouaid, Christos, MD, Dowlati, Afshin, MD, Sanborn, Rachel, MD, Lopez-Chavez, Ariel, MD, Grohe, Christian, Prof, Huber, Rudolf M, Prof, Harbison, Christopher T, PhD, Baudelet, Christine, PhD, Lestini, Brian J, MD, Ramalingam, Suresh S, Prof

Volltext

Nivolumab or nivolumab plus ipilimumab in patients with relapsed malignant pleural mesothelioma (IFCT-1501 MAPS2): a multicentre, open-label, randomised, non-comparative, phase 2 t... von Scherpereel, Arnaud, Mazieres, Julien, Greillier, Laurent, Lantuejoul, Sylvie, Dô, Pascal, Bylicki, Olivier, Monnet, Isabelle, Corre, Romain, Audigier-Valette, Clarisse, Locatelli-Sanchez, Myriam, Molinier, Olivier, Guisier, Florian, Urban, Thierry, Ligeza-Poisson, Catherine, Planchard, David, Amour, Elodie, Morin, Franck, Moro-Sibilot, Denis, Zalcman, Gérard, DEBIEUVRE, Didier, HIRET, Sandrine, CADRANEL, Jacques, FRABOULET-MOREAU, Séverine, CARMIER, Delphine

Volltext

Immune-checkpoint inhibitors associated with interstitial lung disease in cancer patients von Delaunay, Myriam, Cadranel, Jacques, Lusque, Amélie, Meyer, Nicolas, Gounant, Valérie, Moro-Sibilot, Denis, Michot, Jean-Marie, Raimbourg, Judith, Girard, Nicolas, Guisier, Florian, Planchard, David, Metivier, Anne-Cécile, Tomasini, Pascale, Dansin, Eric, Pérol, Maurice, Campana, Marion, Gautschi, Oliver, Früh, Martin, Fumet, Jean-David, Audigier-Valette, Clarisse, Couraud, Sébastien, Dalle, Stéphane, Leccia, Marie-Thérèse, Jaffro, Marion, Collot, Samia, Prévot, Grégoire, Milia, Julie, Mazieres, Julien

Volltext

Size and Concentration of Cell-Free DNA Measured Directly from Blood Plasma, without Prior DNA Extraction von Boutonnet, Audrey, Pradines, Anne, Mano, Marion, Kreczman-Brun, Marion, Mazières, Julien, Favre, Gilles, Ginot, Frédéric

Volltext

Management of pulmonary toxicity associated with immune checkpoint inhibitors von Delaunay, Myriam, Prévot, Grégoire, Collot, Samia, Guilleminault, Laurent, Didier, Alain, Mazières, Julien

Volltext

Lung Cancer That Harbors an HER2 Mutation: Epidemiologic Characteristics and Therapeutic Perspectives von Mazières, Julien, Peters, Solange, Lepage, Benoit, Cortot, Alexis B., Barlesi, Fabrice, Beau-Faller, Michéle, Besse, Benjamin, Blons, Hélène, Mansuet-Lupo, Audrey, Urban, Thierry, Moro-Sibilot, Denis, Dansin, Eric, Chouaid, Christos, Wislez, Marie, Diebold, Joachim, Felip, Enriqueta, Rouquette, Isabelle, Milia, Julie D., Gautschi, Oliver

Volltext

Crizotinib therapy for advanced lung adenocarcinoma and a ROS1 rearrangement: results from the EUROS1 cohort von Mazières, Julien, Zalcman, Gérard, Crinò, Lucio, Biondani, Pamela, Barlesi, Fabrice, Filleron, Thomas, Dingemans, Anne-Marie C, Léna, Hervé, Monnet, Isabelle, Rothschild, Sacha I, Cappuzzo, Federico, Besse, Benjamin, Thiberville, Luc, Rouvière, Damien, Dziadziuszko, Rafal, Smit, Egbert F, Wolf, Jurgen, Spirig, Christian, Pecuchet, Nicolas, Leenders, Frauke, Heuckmann, Johannes M, Diebold, Joachim, Milia, Julie D, Thomas, Roman K, Gautschi, Oliver

Volltext

Efficacy of Immune Checkpoint Inhibitors in Lung Sarcomatoid Carcinoma von Domblides, Charlotte, Leroy, Karen, Monnet, Isabelle, Mazières, Julien, Barlesi, Fabrice, Gounant, Valérie, Baldacci, Simon, Mennecier, Bertrand, Toffart, Anne-Claire, Audigier-Valette, Clarisse, Doucet, Ludovic, Giroux-Leprieur, Etienne, Guisier, Florian, Ricordel, Charles, Molinier, Olivier, Perol, Maurice, Pichon, Eric, Robinet, Gilles, Templement-Grangerat, Dorine, Ruppert, Anne-Marie, Rabbe, Nathalie, Antoine, Martine, Wislez, Marie

Volltext

Durvalumab as third-line or later treatment for advanced non-small-cell lung cancer (ATLANTIC): an open-label, single-arm, phase 2 study von Garassino, Marina Chiara, Kim, Joo-Hang, Corral Jaime, Jesus, Powderly, John, Bidoli, Paolo, Wheatley-Price, Paul, Park, Keunchil, Wadsworth, Catherine, Dennis, Phillip A, Rizvi, Naiyer A, Paz-Ares Rodriguez, Luis, Novello, Silvia, Hiret, Sandrine, Schmid, Peter, Laack, Eckart, Califano, Raffaele, Vicente Baz, David, Berghmans, Thierry, Kim, Dong-Wan, Surmont, Veerle, Reck, Martin, Han, Ji-Youn, Holgado Martin, Esther, Chella, Antonio, Chopra, Akhil, Robinet, Gilles, Soto Parra, Hector, Thomas, Michael, Katakami, Nobuyuki, Su, Wu-Chou, Kim, Young-Chul, Lee, Jong-Seok, Saka, Hideo, Milella, Michele, Ramos Garcia, Inmaculada, Sibille, Anne, Atagi, Shinji, Spaeth-Schwalbe, Ernst, Nishio, Makoto, Imamura, Fumio, Derijcke, Sofie, Maeda, Tadashi, Zylla, Dylan, Santoro, Armando, Uy, Ma. Noemi, Lucien Geater, Sarayut, Kowalski, Dariusz, Chen, Yuh-Min, Spigel, David, Chewaskulyong, Busyamas, Garcia Gomez, Ramon, Alvarez Alvarez, Rosa, Yang, Chih-Hsin, Denis, Fabrice, Sakai, Hiroshi, Canon, Jean-Luc, Scholz, Christian, Kemmotsu, Hirotsugu, Azuma, Koichi, Feld, Ronald, Jassem, Jacek, Kubota, Kaoru, Waterhouse, David, Coudert, Bruno, Mark, Zsuzsanna, Chang, Gee-Chen, Herzmann, Christian, Chaudhry, Arvind, Giridharan, Selvaraj, Hesketh, Paul, Boccia, Ralph, Iannotti, Nichola, Haigentz, Missak, Reynolds, John, Nakagawa, Kazuhiko, Sugawara, Shunichi, Tan, Eng Huat, Takeda, Koji, Mohn-Staudner, Andrea, Panwalkar, Amit, Daniel, Davey, Kobayashi, Kunihiko, Ladrera, Guia Elena Imelda, Coupkova, Helena, Havel, Libor, Singh, Joginder, Murakami, Shuji, Anderson, Ian, Iqbal, Mussawar, Torri, Vamsee, Juhasz, Erzsebet, Koubkova, Leona, Levy, Benjamin, Page, Ray, Crinò, Lucio, Einspahr, David, Hagenstad, Christopher, Juat, Necy, Overton, Lindsay, Szalai, Zsuzsanna

Volltext

Efficacy of Immune Checkpoint Inhibitors in KRAS-Mutant Non-Small Cell Lung Cancer (NSCLC) von Jeanson, Arnaud, Tomasini, Pascale, Souquet-Bressand, Maxime, Brandone, Nicolas, Boucekine, Mohamed, Grangeon, Mathieu, Chaleat, Solène, Khobta, Natalyia, Milia, Julie, Mhanna, Laurent, Greillier, Laurent, Biemar, Julie, Nanni, Isabelle, Ouafik, L’houcine, Garcia, Stéphane, Mazières, Julien, Barlesi, Fabrice, Mascaux, Céline

Volltext